Supernus, Inc.

SUPN Nasdaq SEC CIK 1625297
Follow Supernus Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $356M +13.4% vs same quarter last year
Net income $137M +226.2% vs same quarter last year
EPS, diluted $1.12 +239.4% vs same quarter last year
Operating cash flow $97M +348.7% vs same quarter last year
Revenue by quarter
$299M
$266M
$302M
$314M
$358M
$317M
$343M
$356M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.2B$210M
FY24$1.2B$7M
FY23$1.1B−$126M
FY22$901M−$42M
FY21--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−25%0%25%50%75%100%FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2580.2%21.1%16.9%
FY2480.6%3.2%0.6%
FY2384.1%−13.9%−11.5%
FY2283.1%−8.5%−4.7%
FY21---
Free cash flowOperating cash flow minus capital expenditure
−$400M−$300M−$200M−$100M$0$100MFY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$93M
FY24$7M
FY23−$308M
FY22−$9M
FY21-
Returned to shareholdersDividends paid and shares bought back
$0$50M$100M$150M$200MFY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25$11M
FY24$173M
FY23$33M
FY22$90M
FY21-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Supernus
  • Healthcare median
−100%−75%−50%−25%0%25%FY21FY22FY23FY24FY25
Show the numbers
YearSupernusHealthcare median
FY2516.9%−30.6%
FY240.6%−47%
FY23−11.5%−58%
FY22−4.7%−80.4%
FY21-−71.9%